Abstract
Concerns regarding end-of-life (EOL) chemotherapy are being increasingly raised. Tumor chemosensitivity may influence the decision for aggressive chemotherapy near the EOL. Data on EOL chemotherapy in highly chemosensitive tumors, such as small cell lung cancer (SCLC), are scarce. A total of 143 SCLC decedents were consecutively included. Data about clinical factors and treatment modalities were obtained from the electronic medical records. The relationships among EOL chemotherapy, clinical features, overall survival (OS), and aggressive care were investigated. About 64% of patients had chemosensitive disease. In total, 30.8 and 16.1% of patients received EOL chemotherapy within the last 1 and 2 months of life, respectively. Younger age was associated with a higher rate of EOL chemotherapy. We determined that EOL chemotherapy was related to inferior OS not only in the entire group, but also in the chemosensitive subgroup. Furthermore, more intensive care was observed among patients who underwent EOL chemotherapy compared with those who did not. EOL chemotherapy was correlated with shorter survival and more aggressive care in patients with SCLC. More research is needed to develop indications for terminating palliative chemothera...Continue Reading
References
Sep 1, 1987·European Journal of Cancer & Clinical Oncology·P E PostmusW Bakker
Nov 1, 1987·European Journal of Cancer & Clinical Oncology·G GiacconeA Calciati
Aug 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G GiacconeA Calciati
Apr 16, 2003·Annals of Internal Medicine·Ezekiel J EmanuelArlene S Ash
Jan 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleJane C Weeks
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Natasha B LeighlMartin H N Tattersall
Jul 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robin MatsuyamaThomas J Smith
Aug 23, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·José Ferraz Gonçalves, Carmen Goyanes
Sep 1, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Marcello Tiseo, Andrea Ardizzoni
Dec 22, 2007·Oncology·Young Ho YunDae Seog Heo
Sep 10, 2008·Cancer·Young Hak KimYutaka Nishiwaki
May 27, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S KaoD Adams
Mar 16, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·U NäppäB Axelsson
Sep 16, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Braga
Jan 31, 2012·Acta Oncologica·Tsang-Wu LiuSiew Tzuh Tang
Apr 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lowell E SchnipperDana S Wollins
Mar 7, 2014·BMJ : British Medical Journal·Alexi A WrightHolly G Prigerson
Jun 3, 2015·Cancer·Matthew C CheungNicole Mittmann
Sep 2, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Sang Hyuck KimJong-Hyock Park
Oct 31, 2015·Journal of Cancer·Raphael HagmannSacha I Rothschild
Jun 9, 2016·The Lancet Oncology·Scott J AntoniaEmiliano Calvo
Jun 18, 2016·The Lancet Oncology·Koichi GotoUNKNOWN JCOG0605 investigators
Oct 30, 2016·The Oncologist·Jin ShengLi Zhang
Dec 10, 2016·The Lancet Oncology·Charles M RudinUNKNOWN SCRX16-001 investigators
Dec 21, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P RochigneuxL Morin
Mar 16, 2017·The Lancet Oncology·Evan W AlleyEmilie van Brummelen